ReviewCurrent oncology (Toronto, Ont.)2025

LAG3, TIM3 and TIGIT: New Targets for Immunotherapy and Potential Associations with Radiotherapy.

Camil Ciprian Mireștean et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.